| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063757 Sulfonamide derivatives as antipsychotic agents |
| 03/23/2006 | US20060063026 Solution-processable phosphorescent materials |
| 03/23/2006 | DE102004037428A1 New 2-thienylalkylamino-substituted 1,3,5-triazine derivatives, useful as herbicides, particularly for selective use |
| 03/23/2006 | DE102004036552A1 Aminocarbonyl-substituierte Thiensulfonylamino(thio)carbonyl-triazolin(thi)one Aminocarbonyl-substituted Thiensulfonylamino (thio) carbonyl-triazolin (ethi) ones |
| 03/23/2006 | DE102004036551A1 Dioxazinyl-substituierte Thienylsulfonylaminocarbonylverbindungen Dioxazinyl-substituted thienylsulfonylaminocarbonyl |
| 03/23/2006 | DE102004036550A1 Aminocarbonyl-substituierte Thienylsulfonylharnstoffe Aminocarbonyl-substituted Thienylsulfonylharnstoffe |
| 03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | CA2580627A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
| 03/23/2006 | CA2580243A1 5-heterocyclyl pyrimidines |
| 03/23/2006 | CA2580033A1 Imidazole compound |
| 03/23/2006 | CA2577181A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 03/23/2006 | CA2568832A1 Indole derivatives as antiviral agents |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636214A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 03/22/2006 | EP1636213A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
| 03/22/2006 | EP1636212A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1636211A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1636210A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents |
| 03/22/2006 | EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1636196A1 Novel lactams and uses thereof |
| 03/22/2006 | EP1636192A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 03/22/2006 | EP1636181A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/22/2006 | EP1635834A2 Novel compounds |
| 03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 03/22/2006 | EP1635828A1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/22/2006 | EP1635827A1 Pyridine n-oxides as antiviral agents |
| 03/22/2006 | EP1635817A1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/22/2006 | EP0962456B1 Cyclic ketone derivative and pharmaceutical use thereof |
| 03/22/2006 | CN1751039A Pyridine derivatives as fungicidal compounds |
| 03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
| 03/22/2006 | CN1751036A Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 03/22/2006 | CN1751028A Non-nucleoside reverse transcriptase inhibitors |
| 03/22/2006 | CN1751025A Diamine derivatives |
| 03/22/2006 | CN1751023A Piperidine-benzenesulfonamide derivatives |
| 03/22/2006 | CN1751022A Method for production of the R,R (or S,S) configuration of glycopyrronium stereoisomers |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 03/21/2006 | US7015336 Sub-nanoscale electronic devices and processes |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
| 03/21/2006 | US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine |
| 03/21/2006 | US7014968 Which have good electrostatic properties such as high acceptance voltage and low discharge voltage; electrophotographic apparatuses and imaging methods; 9-(thiiranylmethyl)-3,3'-bicarbazole for example |
| 03/21/2006 | US7014796 Irradiation with microwaves |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2147854C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
| 03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
| 03/16/2006 | WO2006027186A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors |
| 03/16/2006 | WO2005123680B1 Six-membered heterocycles useful as serine protease inhibitors |
| 03/16/2006 | WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/16/2006 | WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 03/16/2006 | WO2005111008A3 Compounds for enzyme inhibition |
| 03/16/2006 | WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators |
| 03/16/2006 | WO2005077344A3 Hydantoin derivatives as inhibitors of cellular necrosis |
| 03/16/2006 | US20060058527 suitable as synthones for the construction of complex molecules containing tetrahydropyran units; pent-1-al and methyl acrylate as starting material for preperation of tetrahydrofurans |
| 03/16/2006 | US20060058523 Quinazoline compounds |
| 03/16/2006 | US20060058522 2-[(aminocarbonyl)amino]-5-(4-{[2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophene-3-carboxamide; I kappa B kinase-1(IKK-1) inhibitors; asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, chronic obstructive pulmonary disease, bone resorptive disease, osteoarthritis |
| 03/16/2006 | US20060058374 Urotensin II receptor agents |
| 03/16/2006 | US20060058367 Synthesis of amines and intermediates for the synthesis thereof |
| 03/16/2006 | US20060058354 Conjugated aromatic compounds with a pyridine substituent |
| 03/16/2006 | US20060058353 Benzofuran derivatives, process for their preparation and intermediates thereof |
| 03/16/2006 | US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | CA2579004A1 Mercaptoamides as histone deacetylase inhibitors |
| 03/15/2006 | EP1633745A1 Aroyl semicarbazide derivatives against thromboembolic diseases |
| 03/15/2006 | EP1633744A1 Sulptionamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633740A2 Chemical compounds |
| 03/15/2006 | EP1633737A1 Quinolyl amide derivatives as ccr-5 antagonists |
| 03/15/2006 | EP1633733A1 Cannabinoid derivatives, methods of making, and use thereof |
| 03/15/2006 | EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists |
| 03/15/2006 | EP1633725A1 Hepatitis c virus inhibitors |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633723A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors |
| 03/15/2006 | EP1633709A1 Anti-diabetic agents |
| 03/15/2006 | EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 03/15/2006 | EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 03/15/2006 | EP1633347A1 2-pyrrolidone derivatives and use thereof as factor xa inhibitors |
| 03/15/2006 | EP1567151B1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |